Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 16 | 2020 | 422 | 3.980 |
Why?
|
| Bronchoscopy | 10 | 2018 | 54 | 1.800 |
Why?
|
| Early Detection of Cancer | 6 | 2020 | 101 | 1.590 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 15 | 0.890 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 116 | 0.870 |
Why?
|
| Endosonography | 2 | 2015 | 55 | 0.860 |
Why?
|
| Lymph Nodes | 2 | 2016 | 113 | 0.810 |
Why?
|
| Clinical Competence | 2 | 2015 | 329 | 0.720 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 108 | 0.660 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 62 | 0.650 |
Why?
|
| Decision Making | 2 | 2019 | 190 | 0.620 |
Why?
|
| Health Services | 1 | 2019 | 40 | 0.600 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 854 | 0.600 |
Why?
|
| Social Class | 1 | 2019 | 90 | 0.590 |
Why?
|
| Middle Aged | 18 | 2020 | 11838 | 0.590 |
Why?
|
| Patient Compliance | 1 | 2020 | 206 | 0.580 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 19 | 0.570 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 32 | 0.570 |
Why?
|
| Attitude to Health | 1 | 2019 | 137 | 0.560 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 52 | 0.550 |
Why?
|
| Lymphoma | 1 | 2018 | 37 | 0.540 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 130 | 0.530 |
Why?
|
| Aged | 14 | 2020 | 10249 | 0.520 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 180 | 0.520 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 6 | 0.510 |
Why?
|
| Ethnic Groups | 1 | 2019 | 450 | 0.510 |
Why?
|
| Cough | 1 | 2017 | 19 | 0.510 |
Why?
|
| Granuloma | 1 | 2016 | 14 | 0.480 |
Why?
|
| Female | 18 | 2020 | 19943 | 0.450 |
Why?
|
| Male | 17 | 2020 | 19437 | 0.450 |
Why?
|
| Humans | 22 | 2020 | 32271 | 0.440 |
Why?
|
| Postoperative Complications | 2 | 2017 | 818 | 0.440 |
Why?
|
| Asthma | 1 | 2017 | 262 | 0.420 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 5 | 0.380 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 93 | 0.370 |
Why?
|
| Ultrasonography, Interventional | 1 | 2012 | 55 | 0.370 |
Why?
|
| Neoplasms | 1 | 2016 | 763 | 0.290 |
Why?
|
| Conscious Sedation | 2 | 2017 | 24 | 0.250 |
Why?
|
| Retrospective Studies | 5 | 2019 | 3609 | 0.250 |
Why?
|
| Mass Screening | 2 | 2019 | 256 | 0.250 |
Why?
|
| Prospective Studies | 4 | 2020 | 2315 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 904 | 0.240 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3893 | 0.220 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 880 | 0.210 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 458 | 0.210 |
Why?
|
| Lymphatic Metastasis | 2 | 2016 | 168 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2015 | 161 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2018 | 1839 | 0.200 |
Why?
|
| Bronchial Neoplasms | 2 | 2013 | 5 | 0.180 |
Why?
|
| Computers, Handheld | 1 | 2019 | 15 | 0.150 |
Why?
|
| Information Seeking Behavior | 1 | 2019 | 9 | 0.150 |
Why?
|
| Consumer Health Information | 1 | 2019 | 15 | 0.150 |
Why?
|
| Preventive Health Services | 1 | 2020 | 39 | 0.150 |
Why?
|
| Income | 1 | 2019 | 66 | 0.150 |
Why?
|
| Cystatin A | 1 | 2019 | 7 | 0.150 |
Why?
|
| Educational Status | 1 | 2019 | 168 | 0.150 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 10 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 39 | 0.140 |
Why?
|
| Access to Information | 1 | 2019 | 13 | 0.140 |
Why?
|
| Adult | 5 | 2018 | 9260 | 0.140 |
Why?
|
| Lung | 1 | 2020 | 263 | 0.140 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2018 | 6 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 18 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 20 | 0.140 |
Why?
|
| Clinical Protocols | 1 | 2018 | 77 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 179 | 0.140 |
Why?
|
| Decision Trees | 1 | 2018 | 30 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 650 | 0.140 |
Why?
|
| False Positive Reactions | 1 | 2017 | 27 | 0.130 |
Why?
|
| Cholinergic Antagonists | 1 | 2017 | 10 | 0.130 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2017 | 15 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 11 | 0.130 |
Why?
|
| Vital Capacity | 1 | 2017 | 37 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 43 | 0.130 |
Why?
|
| Genotype | 1 | 2018 | 702 | 0.130 |
Why?
|
| Forced Expiratory Volume | 1 | 2017 | 81 | 0.130 |
Why?
|
| Prednisolone | 1 | 2017 | 9 | 0.130 |
Why?
|
| Bronchodilator Agents | 1 | 2017 | 34 | 0.130 |
Why?
|
| Smoking | 1 | 2020 | 505 | 0.130 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 59 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 93 | 0.120 |
Why?
|
| Midazolam | 1 | 2016 | 11 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2016 | 18 | 0.120 |
Why?
|
| Fentanyl | 1 | 2016 | 33 | 0.120 |
Why?
|
| Mediastinum | 1 | 2016 | 14 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2016 | 22 | 0.120 |
Why?
|
| United States | 3 | 2020 | 4069 | 0.120 |
Why?
|
| Biopsy | 1 | 2017 | 249 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 115 | 0.120 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 56 | 0.120 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1076 | 0.120 |
Why?
|
| Outpatients | 1 | 2015 | 57 | 0.110 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 13 | 0.110 |
Why?
|
| Lymphatic Diseases | 1 | 2014 | 11 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2017 | 854 | 0.110 |
Why?
|
| Hispanic Americans | 1 | 2019 | 772 | 0.110 |
Why?
|
| Mediastinal Neoplasms | 1 | 2014 | 15 | 0.110 |
Why?
|
| Palliative Care | 1 | 2015 | 50 | 0.110 |
Why?
|
| Leiomyoma | 2 | 2013 | 15 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 130 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 1423 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 637 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 183 | 0.100 |
Why?
|
| African Americans | 1 | 2019 | 1335 | 0.100 |
Why?
|
| Cryotherapy | 1 | 2013 | 12 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 128 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 395 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 287 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 316 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 471 | 0.090 |
Why?
|
| Young Adult | 1 | 2018 | 2651 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 373 | 0.080 |
Why?
|
| Obesity | 1 | 2016 | 1111 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2019 | 309 | 0.070 |
Why?
|
| Eligibility Determination | 1 | 2020 | 18 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2020 | 62 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2019 | 54 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 218 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2019 | 111 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 257 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 156 | 0.030 |
Why?
|
| Internet | 1 | 2019 | 202 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 272 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 305 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 892 | 0.030 |
Why?
|
| Oximetry | 1 | 2016 | 32 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 298 | 0.030 |
Why?
|
| Neck | 1 | 2016 | 32 | 0.030 |
Why?
|
| Research Design | 1 | 2017 | 316 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1529 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2015 | 90 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2238 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 358 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 863 | 0.020 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2013 | 2 | 0.020 |
Why?
|
| Granular Cell Tumor | 1 | 2013 | 2 | 0.020 |
Why?
|
| Bronchial Diseases | 1 | 2013 | 4 | 0.020 |
Why?
|
| Papilloma | 1 | 2013 | 8 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 9 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3408 | 0.010 |
Why?
|